Roche
ROG.SW
$273.34
Share price
-0.91%
Change (1 day)
-13.25%
Change (1 year)
Categories
Roche (ROG.SW) - Cash on Hand
Cash on Hand as of December 2022 : $10.57 B
According to Roche's latest financial reports the company has $10.57 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Roche - Cash on Hand chart (from 2006 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $10.57 B | -25.87% |
| 2021-12-31 | $14.26 B | 1.94% |
| 2020-12-31 | $13.99 B | 14.28% |
| 2019-12-31 | $12.24 B | -8.21% |
| 2018-12-31 | $13.33 B | 8.25% |
| 2017-12-31 | $12.32 B | 37.82% |
| 2016-12-31 | $8.93 B | -3.69% |
| 2015-12-31 | $9.28 B | -21.59% |
| 2014-12-31 | $11.83 B | -12% |
| 2013-12-31 | $13.45 B | -12.25% |
| 2012-12-31 | $15.33 B | 27.42% |
| 2011-12-31 | $12.03 B | 3.14% |
| 2010-12-31 | $11.66 B | -34.96% |
| 2009-12-31 | $17.93 B | -9.95% |
| 2008-12-31 | $19.91 B | -6.84% |
| 2007-12-31 | $21.37 B | 6.9% |
| 2006-12-31 | $19.99 B | 26% |
| 2005-12-31 | $15.87 B | 39.26% |
| 2004-12-31 | $11.39 B | -12.43% |
| 2003-12-31 | $13.01 B | -27.75% |
| 2002-12-31 | $18.01 B | -35.53% |
| 2001-12-31 | $27.94 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.61 B | 132.80% | 🇺🇸 USA |
 Novartis NVS | $11.17 B | 5.69% | 🇨🇭 Switzerland |
 Pfizer PFE | $19.97 B | 88.90% | 🇺🇸 USA |
 Abbott Laboratories ABT | $9.53 B | -9.84% | 🇺🇸 USA |
 Amgen AMGN | $34.24 B | 223.93% | 🇺🇸 USA |
 Sanofi SNY | $8.68 B | -17.84% | 🇫🇷 France |
 Becton Dickinson BDX | $0.93 B | -91.19% | 🇺🇸 USA |
 Merck MRK | $10.38 B | -1.76% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.20 B | -22.40% | 🇬🇧 UK |